These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2002545)

  • 61. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
    Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L
    J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
    Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
    J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An HIV-1 infection-related idiotype/clonotype (1F7) is expressed on antibodies directed to envelope glycoprotein in simian immunodeficiency virus- and chimeric simian/human immunodeficiency virus-infected rhesus monkeys.
    Müller S; Margolin DH; Min G
    Hybridoma; 1997 Feb; 16(1):17-21. PubMed ID: 9085123
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Characterization of N-linked glycosylation sites on envelope proteins of simian/human immunodeficiency virus in peripheral blood of Chinese rhesus macaques during acute infection].
    Shi Y; Wan YM; Chen J; Wang J; Ren YQ; Wei Q; Cong Z; Xu JQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Oct; 50(10):869-873. PubMed ID: 27686764
    [No Abstract]   [Full Text] [Related]  

  • 65. Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein.
    Jurkiewicz E; Hunsmann G; Schäffner J; Nisslein T; Lüke W; Petry H
    J Virol; 1997 Dec; 71(12):9475-81. PubMed ID: 9371609
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).
    Luciw PA; Pratt-Lowe E; Shaw KE; Levy JA; Cheng-Mayer C
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7490-4. PubMed ID: 7638218
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antigenic variation of molecularly cloned SIVmac239 during persistent infection in a rhesus macaque.
    Joag SV; Anderson MG; Clements JE; McEntee MF; Sharma DP; Adams RJ; Narayan O
    Virology; 1993 Aug; 195(2):406-12. PubMed ID: 8337820
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human immunodeficiency virus type 1 envelope epitope-specific CD4(+) T lymphocytes in simian/human immunodeficiency virus-infected and vaccinated rhesus monkeys detected using a peptide-major histocompatibility complex class II tetramer.
    Kuroda MJ; Schmitz JE; Lekutis C; Nickerson CE; Lifton MA; Franchini G; Harouse JM; Cheng-Mayer C; Letvin NL
    J Virol; 2000 Sep; 74(18):8751-6. PubMed ID: 10954578
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivo.
    Luke W; Coulibaly C; Dittmer U; Voss G; Oesterle R; Makoschey B; Sauermann U; Jurkiewicz E; Stahl-Henning C; Petry H; Hunsmann G
    Virology; 1996 Feb; 216(2):444-50. PubMed ID: 8607276
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallenge.
    Lifson JD; Piatak M; Cline AN; Rossio JL; Purcell J; Pandrea I; Bischofberger N; Blanchard J; Veazey RS
    J Med Primatol; 2003 Aug; 32(4-5):201-10. PubMed ID: 14498980
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IL-15 stimulates the expansion of AIDS virus-specific CTL.
    Kanai T; Thomas EK; Yasutomi Y; Letvin NL
    J Immunol; 1996 Oct; 157(8):3681-7. PubMed ID: 8871670
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.
    Amos JD; Himes JE; Armand L; Gurley TC; Martinez DR; Colvin L; Beck K; Overman RG; Liao HX; Moody MA; Permar SR
    J Virol; 2015 Sep; 89(18):9485-98. PubMed ID: 26157116
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac.
    Marthas ML; Ramos RA; Lohman BL; Van Rompay KK; Unger RE; Miller CJ; Banapour B; Pedersen NC; Luciw PA
    J Virol; 1993 Oct; 67(10):6047-55. PubMed ID: 8371353
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD4+ T cell responses to simian immunodeficiency virus.
    Mills KH; Jones WC
    Curr Top Microbiol Immunol; 1994; 188():161-73. PubMed ID: 7924425
    [No Abstract]   [Full Text] [Related]  

  • 76. The appearance of escape variants in vivo does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus.
    Almond N; Jenkins A; Jones S; Arnold C; Silvera P; Kent K; Mills KHG; Stott EJ
    J Gen Virol; 1999 Sep; 80 ( Pt 9)():2375-2382. PubMed ID: 10501490
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques.
    Johnson PR; Hamm TE; Goldstein S; Kitov S; Hirsch VM
    Virology; 1991 Nov; 185(1):217-28. PubMed ID: 1926774
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neutralising epitopes of simian immunodeficiency virus envelope glycoprotein.
    Kent KA
    J Med Primatol; 1995 May; 24(3):145-9. PubMed ID: 8751054
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.
    Clements JE; Montelaro RC; Zink MC; Amedee AM; Miller S; Trichel AM; Jagerski B; Hauer D; Martin LN; Bohm RP
    J Virol; 1995 May; 69(5):2737-44. PubMed ID: 7707496
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Suboptimal nucleotides in the infectious, pathogenic simian immunodeficiency virus clone SIVmac239.
    Alexander L; Denekamp L; Czajak S; Desrosiers RC
    J Virol; 2001 Apr; 75(8):4019-22. PubMed ID: 11264395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.